Tumor Antigens

Biomarker

Also known as: tumor antigens

Related News

Cancer monoclonal antibodies market seen reaching USD 135.2 billion by 2033

Apr 20, 2026

The global cancer monoclonal antibodies market was valued at USD 66.7 billion in 2025 and is expected to reach USD 135.2 billion by 2033. Growth is being driven by targeted therapies, bispecific antibodies, ADCs and checkpoint inhibitors.

Korean Biotechs to Present Next-Gen Cancer Therapies at AACR Meeting

Apr 08, 2026

Korean biotech firms will present next-generation cancer therapies at the AACR meeting, including CAR-T platforms for solid tumors, mRNA-based treatments, radiopharmaceuticals, and bispecific antibody ADCs. Companies like AbClon, Verismo Therapeutics, Hanmi Pharmaceutical, and SK Biopharmaceuticals will showcase their latest research.